Company Data

Lyell Immunopharma Inc.

Ticker
LYEL
Current Price
$9.67 -0.82%
Market Cap
$143.2M
Price Target
Refer to Report
Volume
19.2K
52wk Range
$7.65 - $38.4
Advanced Market Data

Overview

Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy